Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Frackelton

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|June 10, 1980
Functional diversity of antibodies elicited by bacterial beta-D-galactosidase. Monoclonal activating, inactivating, protecting, and null antibodies to normal enzymeA R Frackelton, B Rotman
The Journal of Urology|September 1, 1996
The mitotoxin, basic fibroblast growth factor-saporin, effectively targets human prostatic carcinoma in an animal modelP Davol, A R Frackelton
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1980
Diffusion control of the binding of carcinoembryonic antigen (CEA) with insoluble anti-CEA antibodyA R Frackelton, J K Weltman
Breast Cancer Research and Treatment|August 8, 1998
Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: correlation with ErbB2 and p66 Shc expressionL E Stevenson, A R Frackelton
The Prostate|July 9, 1999
Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: characterizing and circumventing mechanisms of tumor resistanceP A Davol, A R Frackelton
Cancer Research|August 11, 1976
Application of a galactosidase immunosorbent test to carcinoembryonic antigen in plasmaJ K Weltman, A R Frackelton
The American Journal of Physiology|February 1, 1996
The epidermal growth factor receptor network in type 2 pneumocytes exposed to hyperoxia in vitroL Nici, M Medina, A R Frackelton
Anticancer Research|September 2, 1999
Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivoP A Davol, A Bizuneh, A R Frackelton
Cancer|November 5, 1999
Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal modelP A Davol, S Garza, A R Frackelton
The Journal of Investigative Dermatology|June 1, 1995
Autocrine down-regulation of basic fibroblast growth factor receptors causes mitotoxin resistance in a human melanoma cell lineP Davol, J G Beitz, A R Frackelton
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|June 10, 1980
Functional diversity of antibodies elicited by bacterial beta-D-galactosidase. Monoclonal activating, inactivating, protecting, and null antibodies to normal enzymeA R Frackelton, B Rotman
The Journal of Urology|September 1, 1996
The mitotoxin, basic fibroblast growth factor-saporin, effectively targets human prostatic carcinoma in an animal modelP Davol, A R Frackelton
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1980
Diffusion control of the binding of carcinoembryonic antigen (CEA) with insoluble anti-CEA antibodyA R Frackelton, J K Weltman
Breast Cancer Research and Treatment|August 8, 1998
Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: correlation with ErbB2 and p66 Shc expressionL E Stevenson, A R Frackelton
The Prostate|July 9, 1999
Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: characterizing and circumventing mechanisms of tumor resistanceP A Davol, A R Frackelton
Cancer Research|August 11, 1976
Application of a galactosidase immunosorbent test to carcinoembryonic antigen in plasmaJ K Weltman, A R Frackelton
The American Journal of Physiology|February 1, 1996
The epidermal growth factor receptor network in type 2 pneumocytes exposed to hyperoxia in vitroL Nici, M Medina, A R Frackelton
Anticancer Research|September 2, 1999
Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivoP A Davol, A Bizuneh, A R Frackelton
Cancer|November 5, 1999
Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal modelP A Davol, S Garza, A R Frackelton
The Journal of Investigative Dermatology|June 1, 1995
Autocrine down-regulation of basic fibroblast growth factor receptors causes mitotoxin resistance in a human melanoma cell lineP Davol, J G Beitz, A R Frackelton
Pageof 5